MetaCap

Vericel Statistics

NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

57.52-0.74 (-1.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Vericel by the numbers

Vericel has a market capitalization of $2.94 billion based on 51.03M shares outstanding. Its trailing P/E ratio is 89.9, and its forward P/E is 61.1. The stock trades 28.7% above its 50-day average and 44.0% above its 200-day average.

Average daily trading volume is 664.34K shares, or about $38.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VCEL valuation vs. peer median

VCEL compared with the median of 8 peer companies
MetricVCELPeer medianDifference
Market cap$2.94B$3.07B-5%
Forward P/E61.114.1+334%
Avg. volume664.34K2.49M-73%

Peer median across 8 companies: DNLI, ADMA, IOVA, RLAY, TARS, BEAM, CRSP, BCRX.

Valuation

Price / sales (latest FY)
10.62

Price and trading

Previous close
58.26
Open
58.11
Day range
57.33 – 59.49
52-week range
28.95 – 59.75
52-week change
+45.33%
Beta
—
Volume
582.32K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.94B
Pe
89.88
Forward Pe
61.06
Eps
0.64
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
59.75
Week52 Low
28.95
Avg Volume
664.34K
Shares Outstanding
51.03M
Ma50
44.69
Ma200
39.94
Earnings Date
Nov 5, 2026
Pct From52w High
-3.73%
Pct From52w Low
98.69%

Related